Ask Warren

From Bio

377220 · KOSDAQ · ₩377220 · 프롬바이오

₩1,882▼ ₩27 (1.41%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩15B₩19B₩20B₩18B₩16B₩19B₩17B₩14B
Cost of sales₩2.9B₩7B₩10B₩6.6B₩6.8B₩7.1B₩12B₩6B
Gross profit₩12B₩12B₩9.4B₩12B₩9B₩11B₩5.4B₩8.4B
Operating income−₩553M−₩3.3B−₩8B−₩4.4B−₩3.9B−₩2.3B−₩9.8B−₩4.3B
Net income₩2.5B−₩3.7B−₩18B−₩269M−₩1.7B−₩2.9B−₩22B−₩1.8B
Net income to shareholders−₩1.2B−₩3.6B−₩11B−₩4.7B−₩4.4B−₩2.7B−₩12B−₩4.4B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩61B₩61B₩65B₩76B₩78B₩84B₩81B₩92B
Current assets₩15B₩14B₩18B₩25B₩27B₩33B₩29B₩37B
Cash and equivalents₩764M₩1.5B₩2.3B₩2.1B₩3.7B₩5.8B₩2B₩7.1B
Total liabilities₩40B₩38B₩39B₩39B₩36B₩37B₩32B₩31B
Current liabilities₩37B₩36B₩37B₩36B₩34B₩36B₩27B₩26B
Borrowings₩1.8B₩1.8B₩6B₩33B₩32B₩32B₩4.5B₩26B
Total equity₩21B₩22B₩26B₩37B₩42B₩46B₩49B₩61B
Shareholders' equity₩23B₩24B₩28B₩38B₩43B₩48B₩50B₩62B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.4B−₩1B−₩2.7B−₩2.6B−₩1.9B−₩2.9B−₩5.1B−₩4.8B
Capital spending₩147,990₩26M₩259M₩429M₩150M₩267M₩266M₩65M
Free cash flow−₩1.4B−₩1.1B−₩3B−₩3B−₩2B−₩3.1B−₩5.3B−₩4.8B

Consolidated where available. Amounts in won.

Also known as: From Bio / 프롬바이오 / 377220 / KRX:377220

Source: KRX statistical information